FDA Drug Recalls
14,450 recalls · Class II, newest first
Class II · Moderate risk Ongoing Jun 23, 2026
Reason CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Class II · Moderate risk Ongoing Jun 23, 2026
Reason Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Class II · Moderate risk Ongoing Jun 22, 2026
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Class II · Moderate risk Ongoing Jun 17, 2026
Reason Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Class II · Moderate risk Ongoing Jun 16, 2026
Reason Subpotent Drug
Class II · Moderate risk Ongoing Jun 12, 2026
Reason CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been…
Class II · Moderate risk Ongoing Jun 12, 2026
Reason Crystallization; identified as Buprenorphine free base
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 11, 2026
Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead…
Class II · Moderate risk Ongoing Jun 10, 2026
Reason Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Class II · Moderate risk Ongoing Jun 10, 2026
Reason Lack of assurance of Sterility:
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jun 8, 2026
Reason Subpotent Drug
Class II · Moderate risk Ongoing Jun 7, 2026
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing Jun 5, 2026
Reason Failed Dissolution Specifications